Taxane-induced blockade to nuclear accumulation of the androgen receptor predicts clinical responses in metastatic prostate cancer.

Cancer Res 2011 Sep 28;71(18):6019-29. Epub 2011 Jul 28.

Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College of Cornell University, New York, New York 10065-4896, USA.

Prostate cancer progression requires active androgen receptor (AR) signaling which occurs following translocation of AR from the cytoplasm to the nucleus. Chemotherapy with taxanes improves survival in patients with castrate resistant prostate cancer (CRPC). Taxanes induce microtubule stabilization, mitotic arrest, and apoptotic cell death, but recent data suggest that taxanes can also affect AR signaling. Here, we report that taxanes inhibit ligand-induced AR nuclear translocation and downstream transcriptional activation of AR target genes such as prostate-specific antigen. AR nuclear translocation was not inhibited in cells with acquired β-tubulin mutations that prevent taxane-induced microtubule stabilization, confirming a role for microtubules in AR trafficking. Upon ligand activation, AR associated with the minus-end-microtubule motor dynein, thereby trafficking on microtubules to translocate to the nucleus. Analysis of circulating tumor cells (CTC) isolated from the peripheral blood of CRPC patients receiving taxane chemotherapy revealed a significant correlation between AR cytoplasmic sequestration and clinical response to therapy. These results indicate that taxanes act in CRPC patients at least in part by inhibiting AR nuclear transport and signaling. Further, they suggest that monitoring AR subcellular localization in the CTCs of CRPC patients might predict clinical responses to taxane chemotherapy.

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-11-1417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354631PMC
September 2011
28 Reads

Publication Analysis

Top Keywords

crpc patients
12
prostate cancer
12
androgen receptor
8
taxane chemotherapy
8
clinical responses
8
microtubule stabilization
8
nuclear translocation
8
taxanes
5
activation target
4
genes prostate-specific
4
target genes
4
clinical response
4
transcriptional activation
4
patients inhibiting
4
sequestration clinical
4
prostate-specific antigen
4
inhibited cells
4
cells acquired
4
translocation inhibited
4
cytoplasmic sequestration
4

Similar Publications